Daratumumab or active monitoring for high-risk smoldering multiple myeloma - Dimopoulos, Meletios A.; Voorhees, Peter M.; Schjesvold, Fredrik; Cohen, Yael C.; Hungria, Vania; Sandhu, Irwindeep; Lindsay, Jindriska; Baker, Ross I.; Suzuki, Kenshi; Kosugi, Hiroshi; Levin, Mark-David; Beksac, Meral; et al. (The New England journal of medicine, 2025)
Veröffentlicht: 09. Dezember 2024